ArticleMedicina (Kaunas, Lithuania)2025
Switching to Long-Acting Cabotegravir and Rilpivirine in Turkey: Perspectives from People Living with HIV in a Setting of Increasing HIV Incidence.
Rıdvan Dumlu, Yeliz Çiçek, Mahir Kapmaz, Okan Derin, Halis Akalın, Uğur Önal, Egemen Özdemir, Çiğdem Ataman Hatipoğlu, Günay Tuncer Ertem, Alper Şener and 12 more
Abstract readMulticenter Study
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
22 authors.
Rıdvan DumluDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medipol University, Istanbul 34214, Turkey.ORCID 0000-0001-8213-6064 Yeliz ÇiçekDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medipol University, Istanbul 34214, Turkey.ORCID 0000-0002-4061-2322 Mahir KapmazDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medipol University, Istanbul 34214, Turkey.ORCID 0000-0002-4115-3914 Okan DerinEpidemiology PhD Program, Graduate School of Health Sciences, Istanbul Medipol University, Istanbul 34810, Turkey.ORCID 0000-0001-6311-5428 Halis AkalınDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bursa Uludağ University, Bursa 16059, Turkey.ORCID 0000-0001-7530-1279 Uğur ÖnalDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bursa Uludağ University, Bursa 16059, Turkey.ORCID 0000-0001-6194-3254 Egemen ÖzdemirDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Bursa Uludağ University, Bursa 16059, Turkey.ORCID 0000-0003-2890-6392 Çiğdem Ataman HatipoğluDepartment of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara 06230, Turkey.
Günay Tuncer ErtemDepartment of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara 06230, Turkey.ORCID 0000-0001-8760-0030 Alper ŞenerDepartment of Infectious Diseases and Clinical Microbiology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir 35360, Turkey.
Leyla AkgülDepartment of Infectious Diseases and Clinical Microbiology, Izmir Katip Celebi University, Ataturk Training and Research Hospital, Izmir 35360, Turkey.
Yeşim ÇağlarDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Balikesir University, Balikesir 10145, Turkey.ORCID 0000-0003-2298-7531 Derya Tuna EcerDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Balikesir University, Balikesir 10145, Turkey.
Mustafa Kemal ÇelenDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Dicle University, Diyarbakir 21280, Turkey.
Nur Bahar OğuzDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Dicle University, Diyarbakir 21280, Turkey.ORCID 0009-0002-6502-3193 Figen YıldırımDepartment of Infectious Diseases and Clinical Microbiology, Antalya Vakif Yasam Hospital, Antalya 07060, Turkey.
Deniz BorcakDepartment of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul 34147, Turkey.ORCID 0000-0001-7769-4555 Sevtap ŞenoğluDepartment of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul 34147, Turkey.
Eyüp ArslanDepartment of Infectious Diseases and Clinical Microbiology, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul 34785, Turkey.ORCID 0000-0002-5490-465X Sinan ÇetinDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Giresun University, Giresun 28200, Turkey.
Meryem BalcıDepartment of Infectious Diseases and Clinical Microbiology, Hakkari State Hospital, Hakkari 30000, Turkey.
Ali MertDepartment of Internal Medicine, Faculty of Medicine, Istanbul Medipol University, Istanbul 34214, Turkey.ORCID 0000-0001-8945-2385 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Anti-HIV AgentsDrug SubstitutionHIV InfectionsPyridonesRilpivirineAdultCross-Sectional StudiesDiketopiperazinesFemaleHumansIncidenceMaleMiddle AgedProspective StudiesTurkeyAnti-HIV AgentscabotegravirDiketopiperazinesPyridonesRilpivirinecabotegravir/rilpivirinelong-acting injectable therapymotivational factorsPLWH perspectivesTurkey
Identifiers
PMID40870416
PMCPMC12388033
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390